Emergent BioSolutions launches

ROCKVILLE, Md. — Emergent BioSolutions has launched, a website that provides information about BioThrax, its vaccine for the prevention of anthrax infection.

The website has information on BioThrax, published data and updates to prescribing information. In December 2008, the FDA approved the five-dose schedule and intramuscular route of administration for BioThrax.

BioThrax, the only FDA-licensed anthrax vaccine, is commercially available in the United States and in certain international markets. is designed to be a central resource for government entities, health professionals and people who have been vaccinated, including military personnel, emergency responders, and other individuals at high risk of exposure to anthrax.

The website also provides facts on anthrax disease and the use of anthrax as a potential weapon of bioterrorism.